ALT

What it actually measures

ALT is an enzyme that lives inside your liver cells, where it does ordinary metabolic work converting one amino acid into another.

It is not supposed to be in your blood in any quantity. When it turns up there, it generally means liver cells have been damaged and their contents have leaked out.

So ALT is a damage marker rather than a function marker, and that distinction matters. It tells you cells are being injured. It does not tell you how well your liver is doing its job, which is what albumin, bilirubin and clotting times speak to.

It is reasonably liver-specific, which is why it is preferred over AST for this purpose. AST is also found in muscle and heart, so a hard workout can raise it without any liver involvement at all.

That specificity is why ALT sits on nearly every standard metabolic panel, and it means most people reading this have had it measured, probably repeatedly.

What a normal ALT does not rule out

Here is the finding that reframes this marker.

A 2024 editorial in the World Journal of Gastroenterology discussed a study in which 83.12 percent of people with a diagnosis of metabolic dysfunction-associated fatty liver disease had a normal ALT.

More than four in five, diagnosed with the condition, with a liver enzyme their doctor would describe as normal.

That is the argument behind a long-running debate about whether the upper limit of normal for ALT should be lowered. The reference range was derived from populations that included a great many people with undiagnosed fatty liver, which means normal partly describes what is common rather than what is healthy.

Now the honest counterweight, because the editorial gave it and I would rather pass on both halves. Its authors argued there is not currently a good argument for widespread screening with a reduced ALT level, largely because it is unlikely to be cost-effective, and suggested existing scoring systems such as fibrosis-4 may be amended instead.

They also noted there is not yet a suitable screening test to identify these patients in the general population, and that most are found only after an abnormal ALT turns up incidentally.

So the honest position is not that the range is simply wrong. It is that a normal ALT is weaker reassurance about your liver than most people take it to be, and that the answer at population level is more complicated than moving a line.

For you individually, the useful consequence is different from the policy one: if you have metabolic risk factors, a normal ALT does not close the question.

What moves it

Down: losing excess weight, particularly visceral fat, which is the most effective single change for metabolic fatty liver. Reducing alcohol. Improving insulin sensitivity through resistance training and reduced refined carbohydrate. Treating an underlying cause where one exists. Values also drift down as recovery happens after any acute liver insult.

Up: fatty liver from metabolic causes, which is now the most common reason for a mildly raised ALT. Alcohol. Viral hepatitis. Some medications, including paracetamol in overdose, statins occasionally, and several others. Autoimmune and genetic liver conditions. Coeliac disease, which is worth knowing since it is often missed. And, mildly and temporarily, intense exercise.

The honest hedge

I am not a doctor and I am not diagnosing anyone.

A genuinely raised ALT needs a cause found rather than a supplement started, and the list of causes includes things that matter enormously to catch. Viral hepatitis is treatable. Autoimmune and genetic liver conditions need specialist care. That is a doctor conversation.

I also want to be careful in the other direction. A mildly raised ALT is extremely common and is most often metabolic fatty liver, which is serious in aggregate and highly responsive to weight, alcohol and insulin sensitivity. That is not a reason for panic, it is a reason to act.

On the threshold debate, I have given you both sides deliberately. The 83 percent figure is striking and the editorial arguing against simply lowering the cutoff is also making a reasonable point about screening economics. Both are true.

One practical note that trips people up: liver enzymes fluctuate, and a single mildly raised value is often worth repeating before anyone acts on it.

And ALT is a damage marker, so a normal value in someone with established cirrhosis can be normal precisely because there are fewer cells left to leak. That is rare and it is worth knowing the marker has that failure mode.

So. What to actually do.

Tonight, at no cost. Find your ALT on your last panel and note the number rather than the word normal. Then find your previous ones. A value drifting upward inside the range is information a single report cannot give you.

Be honest about alcohol. It is the most common modifiable cause and the one people most consistently under-report to themselves.

Check the metabolic picture alongside it. Fasting insulin with HbA1c, and your triglyceride to HDL ratio, which you can calculate free. Metabolic fatty liver and insulin resistance travel together.

If it is raised, repeat before acting. Liver enzymes fluctuate, and one mildly raised value often normalises.

If it stays raised, get the cause found. That is a doctor conversation, and the list includes conditions that are genuinely treatable.

Do not treat a normal ALT as a clean bill of liver health. If you carry metabolic risk factors, the question stays open.

Work the levers that move it. Visceral fat down, alcohol down, insulin sensitivity up. Those are the same levers that move most of this section.

You are not fine because a number came back inside a range built from a population that was not especially well.

Your body is not broken. It is blocked. And sometimes the block is a liver quietly accumulating fat, in four out of five cases without ever pushing the enzyme past the line anyone was watching.

Go look at the number rather than the word.